Swiss manufacturers of medical equipment confront challenges from potential US tariffs, threatening key export market for precision instruments and healthcare technology.
"Switzerland has a very favourable labour framework that allows companies to really innovate, thanks to universities that systematically rank in the global top ten"
"It is a frightening moment, because Switzerland is expensive and it's a small country, so you can't scale your production as much as competitors. A 31% tariff would basically kill the chances of companies to sell in the US"
Switzerland's prestigious medical device industry faces unprecedented challenges as US trade pressures threaten to reshape its global market position. The industry, known for its precision instruments and innovative healthcare technology, stands at a critical juncture as potential US tariffs loom over this vital export sector.
Switzerland's medical device sector boasts an impressive 1,400 active companies as of 2023, showcasing remarkable density for a small nation. The country's success in this sector stems from its exceptional labor framework, world-class universities, and presence of major corporate entities. Swiss manufacturers have established themselves as global leaders in specialized medical equipment, from surgical instruments to diagnostic devices.
The industry faces significant uncertainty with potential US tariff increases. Initially threatened with a 31% import tax, substantially higher than the EU's 20%, Swiss manufacturers now operate under a temporary reprieve until July 9. The current 10% tariff rate, while manageable, could escalate dramatically, threatening the industry's competitiveness in the crucial US market, which accounts for a significant portion of Switzerland's medical device exports.
The stakes are particularly high given that Switzerland exported CHF 2.8 billion worth of medical goods to the US in 2024. A 31% tariff could result in additional costs exceeding CHF 800 million, potentially devastating for the industry. The complex, cross-border value chains characteristic of medical device manufacturing make the sector particularly vulnerable to trade disruptions. Industry leaders express concern about maintaining competitiveness while facing these potential cost increases.